Artelo Biosciences
Stock Forecast, Prediction & Price Target
Artelo Biosciences Financial Estimates
Artelo Biosciences Revenue Estimates
Artelo Biosciences EBITDA Estimates
Artelo Biosciences Earnings per Share Estimates
Passed | Analyst forecast | ||||||
---|---|---|---|---|---|---|---|
Metric | 8/31/2020 | 8/31/2021 | 12/31/2022 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $0 N/A | $0 0% | $0 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $49.28M Low: $49.28M High: $49.28M avg. 0% | Avg: $91.44M Low: $91.44M High: $91.44M avg. 85.54% |
Net Income
% change YoY
| $-4.65M N/A | $-7.43M -59.76% | $-9.87M -32.76% | Avg: $-14.37M Low: $-3.42M High: $-2.09M avg. -45.54% | Avg: $-20.46M Low: $-2.86M High: $-1.50M avg. -42.43% | Avg: $2.09M Low: $2.09M High: $2.09M avg. 110.24% | Avg: $5.53M Low: $5.53M High: $5.53M avg. 164.18% |
EBITDA
% change YoY
| $-4.71M N/A | $-7.44M -57.86% | $-10.28M -38.18% | Avg: $0 Low: $0 High: $0 avg. 100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
EPS
% change YoY
| -$18.83 N/A | -$5.97 68.29% | -$3.49 41.54% | Avg: -$0.94 Low: -$1.21 High: -$0.74 avg. 72.97% | Avg: -$0.77 Low: -$1.01 High: -$0.53 avg. 18.37% | Avg: $0.74 Low: $0.74 High: $0.74 avg. 196.10% | Avg: $1.96 Low: $1.96 High: $1.96 avg. 164.18% |
Operating Expenses
% change YoY
| $4.68M N/A | $7.44M 58.79% | $10.28M 38.24% | Avg: $0 Low: $0 High: $0 avg. -100% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% | Avg: $0 Low: $0 High: $0 avg. 0% |
FAQ
What is Artelo Biosciences stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 46.61% in 2025-2028.
We have gathered data from 2 analysts. Their low estimate is -3.42M, average is -14.37M and high is -2.09M.
What is Artelo Biosciences stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 21.38% in 2025-2028.
We have gathered data from 3 analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.
What is Artelo Biosciences stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 112.90% in 2025-2028.
We have gathered data from 2 analysts. Their low earnings per share estimate is -$1.21, average is -$0.94 and high is $-0.74.